Decentralized Clinical Trials: The Role of Blockchain in Biostatistics

Abstract

This paper explores the transformative potential of decentralized clinical trials (DCTs) and the pivotal role of blockchain technology in enhancing biostatistics within this innovative paradigm. Decentralized clinical trials represent a shift from traditional, centralized models, offering increased participant accessibility and real- world data integration. The abstract delves into the conceptual foundations of DCTs, emphasizing how blockchain ensures the integrity, security, and transparency of biostatistical processes. Real-world applications, benefits, and challenges are examined, providing valuable insights into the revolutionary impact of blockchain in biostatistics within the realm of decentralized clinical trials.